Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Elpamotide |
| Synonyms | |
| Therapy Description |
Elpamotide (VEGFR2-169) is a KDR (VEGFR2) HLA-A*2402 allele specific peptide vaccine, which may stimulate cytotoxic T cell response against tumor cells expressing VEGFR2 (KDR) (PMID: 25867139, PMID: 25502982). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Elpamotide | VEGFR2-169 | Elpamotide (VEGFR2-169) is a KDR (VEGFR2) HLA-A*2402 allele specific peptide vaccine, which may stimulate cytotoxic T cell response against tumor cells expressing VEGFR2 (KDR) (PMID: 25867139, PMID: 25502982). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|